News Keep up to date with the latest news from the NC3Rs Innovation team, including updates on CRACK IT Challenges and new 3Rs products. Subscribe to the NC3Rs newsletter
£1M awarded for in vitro and in silico approaches to better predict developmental toxicity in drug development A team led by Dr Amer Jamalpoor at Toxys has proceeded to the next stage of the CrossDART CRACK IT Challenge to develop and qualify multi-species in vitro assays to reduce reliance on in vivo embryo-fetal developmental studies. 17 December 2024
Shaping the future of 3Rs innovation: Professor Mike Capaldi on the 2025 CRACK IT open call As we open the call for 2025 CRACK IT Challenge ideas, we sat down with the Chair of our CRACK IT Advisory Panel, Professor Mike Capaldi, to discuss innovation and the 3Rs. 13 December 2024
Submit your 2025 CRACK IT Challenge ideas Do you have an idea to improve R&D and refine or reduce your reliance on in vivo studies? We want to hear from you. 21 November 2024
£100k awarded to develop methods to identify individual mice from birth A team led by Dr Adam Polak at the Fraunhofer UK Research Ltd has been awarded £100k to develop a non-invasive and non-toxic method to identify individual mice from birth. 24 September 2024
2024 CRACK IT Challenges open for applications The 2024 CRACK IT Challenges Competition is now closed. 23 September 2024
£2.1M funding available through the CRACK IT Challenges competition Two Challenges in the areas of new approach methodologies (NAMs) for avian toxicity testing and to improve the post-operative care of rodents have been launched. 01 August 2024
£600k awarded for proof-of-concept studies to advance the development of New Approach Methodologies Six teams have been awarded up to £100k each in CRACK IT Challenge funding to deliver proof-of-concept studies to address two Challenges that aim to accelerate the development and use of New Approach Methodologies. 15 February 2024
£1M awarded to replace animal studies and improve the safety assessment of cell therapies A team led by Professor Toni Cathomen at the University of Freiburg (Germany) has secured £1M of CRACK IT Challenge funding to develop an approach to evaluate the tumourigenicity of human engineered T cell therapies. 24 January 2024
Sponsor a Challenge: overcome scientific barriers with 3Rs-driven solutions Sponsor a Challenge: overcome scientific barriers with 3Rs-driven solutions. We are looking for stakeholders from across the biosciences to submit their ideas for new CRACK IT Challenges. 08 December 2023